Nonsense Mediated Decay Resistant Mutations Are a Source of Expressed Mutant Proteins in Colon Cancer Cell Lines with Microsatellite Instability

Background Frameshift mutations in microsatellite instability high (MSI-High) colorectal cancers are a potential source of targetable neo-antigens. Many nonsense transcripts are subject to rapid degradation due to nonsense-mediated decay (NMD), but nonsense transcripts with a cMS in the last exon or near the last exon-exon junction have intrinsic resistance to nonsense-mediated decay (NMD). NMD-resistant transcripts are therefore a likely source of expressed mutant proteins in MSI-High tumours. Methods Using antibodies to the conserved N-termini of predicted mutant proteins, we analysed MSI-High colorectal cancer cell lines for examples of naturally expressed mutant proteins arising from frameshift mutations in coding microsatellites (cMS) by immunoprecipitation and Western Blot experiments. Detected mutant protein bands from NMD-resistant transcripts were further validated by gene-specific short-interfering RNA (siRNA) knockdown. A genome-wide search was performed to identify cMS-containing genes likely to generate NMD-resistant transcripts that could encode for antigenic expressed mutant proteins in MSI-High colon cancers. These genes were screened for cMS mutations in the MSI-High colon cancer cell lines. Results Mutant protein bands of expected molecular weight were detected in mutated MSI-High cell lines for NMD-resistant transcripts (CREBBP, EP300, TTK), but not NMD-sensitive transcripts (BAX, CASP5, MSH3). Expression of the mutant CREBBP and EP300 proteins was confirmed by siRNA knockdown. Five cMS-bearing genes identified from the genome-wide search and without existing mutation data (SFRS12IP1, MED8, ASXL1, FBXL3 and RGS12) were found to be mutated in at least 5 of 11 (45%) of the MSI-High cell lines tested. Conclusion NMD-resistant transcripts can give rise to expressed mutant proteins in MSI-High colon cancer cells. If commonly expressed in primary MSI-High colon cancers, MSI-derived mutant proteins could be useful as cancer specific immunological targets in a vaccine targeting MSI-High colonic tumours.

[1]  A. Burgess,et al.  Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B‐Raf , 2009, International journal of cancer.

[2]  M. Linnebacher,et al.  Identification of an MSI-H Tumor-Specific Cytotoxic T Cell Epitope Generated by the (−1) Frame of U79260(FTO) , 2010, Journal of biomedicine & biotechnology.

[3]  S. Kirkland.  Dome formation by a human colonic adenocarcinoma cell line (HCA-7). , 1985, Cancer research.

[4]  M. Kloor,et al.  Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome , 2010, Familial Cancer.

[5]  R. Whitehead,et al.  A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. , 1987, Cancer research.

[6]  A. de la Chapelle,et al.  Immunology and the Lynch syndrome. , 2008, Gastroenterology.

[7]  Sung Mi Park,et al.  Selective Translational Repression of Truncated Proteins from Frameshift Mutation-Derived mRNAs in Tumors , 2007, PLoS biology.

[8]  A. Leibovitz,et al.  Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.

[9]  M. Kloor,et al.  Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  P. V. van Eeden,et al.  A cell line (LIM 2463) derived from a tubulovillous adenoma of the rectum , 1991, International journal of cancer.

[11]  S. Markowitz,et al.  Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability , 2004, Oncogene.

[12]  K. Rock,et al.  Cellular protein is the source of cross-priming antigen in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Yan P. Yuan,et al.  Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes , 2003, Oncogene.

[14]  M. von Knebel Doeberitz,et al.  Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells. , 2004, Cancer immunity.

[15]  M. Brattain,et al.  Heterogeneity of malignant cells from a human colonic carcinoma. , 1981, Cancer research.

[16]  L. Maquat.  Nonsense-mediated mRNA decay , 2002, Current Biology.

[17]  Y. Ionov,et al.  A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Mathias M Schuler,et al.  SYFPEITHI: database for searching and T-cell epitope prediction. , 2007, Methods in molecular biology.

[19]  R. Johnstone,et al.  Tumor localization by combinations of monoclonal antibodies in a new human colon carcinoma cell line (LIM1899). , 1990, Cancer research.

[20]  Mari Mino-Kenudson,et al.  Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype , 2009, Clinical Cancer Research.

[21]  A. Hecht,et al.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets , 2009, Nucleic acids research.

[22]  I. Saeterdal,et al.  A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells. , 2001, Cancer immunology, immunotherapy : CII.

[23]  S. H. van der Burg,et al.  Prediction of the immunogenic potential of frameshift‐mutated antigens in microsatellite instable cancer , 2008, International journal of cancer.

[24]  J. Trapani,et al.  Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2. , 2005, Biochemical and biophysical research communications.

[25]  Yan P. Yuan,et al.  Frameshift peptide‐derived T‐cell epitopes: A source of novel tumor‐specific antigens , 2001, International journal of cancer.

[26]  Timothy J. Yeatman,et al.  DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers , 2008, Clinical Cancer Research.

[27]  Shin Sasaki,et al.  Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. , 2006, Cancer research.

[28]  B. Uzzan,et al.  Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. , 2009, European journal of cancer.

[29]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[30]  H. Eisen,et al.  Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.

[31]  Matej Horvat,et al.  Microsatellite instability in colorectal cancer , 2011, Radiology and oncology.

[32]  John D Potter,et al.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. , 2007, Gastroenterology.

[33]  N. Marcon,et al.  Missed Adenomas during Colonoscopic Surveillance in Individuals with Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) , 2008, Cancer Prevention Research.

[34]  G. Gaudernack,et al.  A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells , 2001, Cancer Immunology, Immunotherapy.

[35]  J. Gebert,et al.  Identification of an HLA-A0201-Restricted CTL Epitope Generated by a Tumor-Specific Frameshift Mutation in a Coding Microsatellite of the OGT Gene , 2003, Journal of Clinical Immunology.

[36]  Randall G. Lee,et al.  Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer. , 2009, Archives of surgery.

[37]  J. Nesland,et al.  Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B Drewinko,et al.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.

[39]  R. Whitehead,et al.  A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. , 1985, Journal of the National Cancer Institute.

[40]  A. Duval,et al.  Genetic instability in human mismatch repair deficient cancers. , 2002, Annales de genetique.

[41]  M. Walker,et al.  A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells , 2007, British Journal of Cancer.

[42]  Yan P. Yuan,et al.  Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair‐deficient cancer cells , 2001, International journal of cancer.

[43]  D Middleton,et al.  New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.

[44]  Y. Niv.  Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer. , 2007, World journal of gastroenterology.

[45]  E. Lundberg,et al.  A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies* , 2008, Molecular & Cellular Proteomics.

[46]  S. von Kleist,et al.  Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. , 1975, Journal of the National Cancer Institute.

[47]  E. Gilboa,et al.  Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay , 2010, Nature.

[48]  G. Thomas,et al.  Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers. , 2005, Human molecular genetics.

[49]  R. Houlston,et al.  Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Derek Middleton,et al.  New allele frequency database: www.allelefrequencies.net , 2003 .

[51]  Yan P. Yuan,et al.  SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology , 2009, Nucleic Acids Res..

[52]  S. Bustin,et al.  Tumour‐infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic , 2004, The British journal of surgery.

[53]  D. Cane,et al.  The nonsense-mediated decay RNA surveillance pathway. , 2007, Annual review of biochemistry.

[54]  M. Kloor,et al.  Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. , 2008, Gastroenterology.

[55]  S. Okabe,et al.  Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. , 2003, Cancer research.

[56]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[57]  T. Frebourg,et al.  Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations , 2009, Modern Pathology.